Actinium Pharmaceuticals
Earnings Surprise
Analysts estimated ATNM earnings of $-0.19 per share this quarter (Q4). ATNM's actual earnings were $-0.20 per share.
ATNM EPS surprise of -5.04%Analysts estimated ATNM earnings of $-0.33 per share this quarter (Q3). ATNM's actual earnings were $-0.16 per share.
ATNM EPS surprise of 51.49%Analysts estimated ATNM earnings of $-0.36 per share this quarter (Q2). ATNM's actual earnings were $-0.22 per share.
ATNM EPS surprise of 38.38%Analysts estimated ATNM earnings of $-0.28 per share this quarter (Q1). ATNM's actual earnings were $-0.51 per share.
ATNM EPS surprise of -80.15%Analysts estimated ATNM earnings of $-0.38 per share this quarter (Q4). ATNM's actual earnings were $-0.21 per share.
ATNM EPS surprise of 44.95%Analysts estimated ATNM earnings of $-0.34 per share this quarter (Q3). ATNM's actual earnings were $-0.37 per share.
ATNM EPS surprise of -7.97%Analysts estimated ATNM earnings of $-0.41 per share this quarter (Q2). ATNM's actual earnings were $-0.38 per share.
ATNM EPS surprise of 8.01%Analysts estimated ATNM earnings of $-0.53 per share this quarter (Q1). ATNM's actual earnings were $-0.31 per share.
ATNM EPS surprise of 41.55%Analysts estimated ATNM earnings of $-0.55 per share this quarter (Q4). ATNM's actual earnings were $-0.34 per share.
ATNM EPS surprise of -38.27%Analysts estimated ATNM earnings of $-0.54 per share this quarter (Q3). ATNM's actual earnings were $-0.49 per share.
ATNM EPS surprise of -9.64%